Today: 27 April 2026
Browse Category

SWX:ZURN.SW 18 November 2025 - 5 March 2026

Beazley profit slides 19% as Zurich takeover advances and board adds PwC veteran Roy Clark

Beazley profit slides 19% as Zurich takeover advances and board adds PwC veteran Roy Clark

Beazley reported a 19% drop in annual pre-tax profit to $1.15 billion as cyber underwriting shrank and insurance pricing weakened. Zurich Insurance’s agreed takeover values Beazley at £8.1 billion, with shareholders set to receive 1,335 pence per share including a 25 pence dividend. Zurich raised $5 billion in a share sale to fund the deal. Beazley shares were little changed in early London trading.
Zurich’s $11 billion Beazley takeover: the 1,335p offer, the financing, and what could derail it

Zurich’s $11 billion Beazley takeover: the 1,335p offer, the financing, and what could derail it

Zurich Insurance Group agreed to acquire Beazley for £8.1 billion ($10.8 billion) in cash. Beazley shareholders will receive 1,335 pence per share, including a 25 pence dividend. Zurich raised CHF 3.9 billion ($5.0 billion) through a new share placement to help fund the deal. The transaction is expected to close in the second half of 2026, pending approvals.
Zurich’s £8bn Beazley bid jolts FTSE 100 to a fresh record as GSK rallies, AI fears hit data stocks

Zurich’s £8bn Beazley bid jolts FTSE 100 to a fresh record as GSK rallies, AI fears hit data stocks

Zurich Insurance has proposed to buy Beazley for up to 1,335 pence per share, valuing the deal at about £8 billion. Beazley’s board said it would support the offer if Zurich makes a firm bid by Feb. 16. Beazley shares rose 9% on the news. The FTSE 100 hit a new intraday high, with GSK up and Relx and LSEG under pressure from AI concerns.
Swiss Stock Market Today, 26 November 2025: SMI Edges Higher as Sentiment Surges and Insurers Face Tougher Rules

Swiss Stock Market Today, 26 November 2025: SMI Edges Higher as Sentiment Surges and Insurers Face Tougher Rules

The Swiss Market Index closed up 0.07% at 12,781.09 on Wednesday, its highest in about a week, extending a three-day advance. Turnover topped 2.4 million contracts. Investor sentiment jumped after a thaw in Swiss-US trade tensions. Zurich Insurance, Swiss Re, and Swiss Life drew attention after being added to the G20 Financial Stability Board’s insurer resolution list.
Swiss Stock Market Today, November 18, 2025: SMI Slips as Roche Soars, ABB, Zurich and ams-Osram Drag the Index

Swiss Stock Market Today, November 18, 2025: SMI Slips as Roche Soars, ABB, Zurich and ams-Osram Drag the Index

The Swiss Market Index fell 0.7% to 12,505 by late morning on November 18, 2025, as global equity declines hit financials and industrials. Roche jumped over 6% to a multi-month high after announcing positive phase III results for its breast cancer drug. ABB, Zurich Insurance, and ams-Osram dropped following investor updates and earnings news. Broader European indices also traded sharply lower.

Stock Market Today

  • SQM Valuation Under Scrutiny Amid New Lithium Oversupply Concerns
    April 27, 2026, 5:29 PM EDT. Sociedad Química y Minera de Chile (SQM) faces fresh lithium market oversupply concerns raised by Rothschild & Co Redburn research. Despite recent share price gains-up 7.36% in 30 days and 27.33% year-to-date-SQM trades at $88.79 against a perceived fair value of $75.33, implying a 17.9% overvaluation. Expansion plans in Australia and Chile, including projects like Salar Futuro, bolster long-term growth potential, but lithium price volatility and Chilean regulatory risks cloud the outlook. Conflicting discounted cash flow (DCF) models add uncertainty, with one suggesting an intrinsic value of $113.84, highlighting divergent investor perspectives on SQM's earnings and growth prospects in a shifting lithium market.

Latest article

3I/ATLAS Comet’s Strange Water Points To A Birthplace Unlike Our Solar System

3I/ATLAS Comet’s Strange Water Points To A Birthplace Unlike Our Solar System

27 April 2026
Astronomers using ALMA have measured deuterated water in interstellar comet 3I/ATLAS, finding a deuterium-to-hydrogen ratio over 40 times higher than Earth’s oceans. The result indicates the comet formed in a much colder environment than the early solar system. The data were collected just after the comet’s perihelion as it now leaves the solar system.
Oruka Therapeutics Stock Surges After Psoriasis Drug Data as Biotech Seeks $500 Million

Oruka Therapeutics Stock Surges After Psoriasis Drug Data as Biotech Seeks $500 Million

27 April 2026
Oruka Therapeutics reported its experimental psoriasis drug ORKA-001 achieved complete skin clearance in 63.5% of patients at 16 weeks. Shares jumped 10.5% to $76.39 before the company launched a $500 million public offering. No serious adverse events were reported in the trial. ORKA-001 is being developed as a long-acting injectable, with annual dosing possible.
Go toTop